Uterine Cancer Study Act of 2025

This bill orders a federal health study on whether chemical hair straighteners are linked to uterine cancer, with special attention to higher rates among women of color. The study must also look at impacts across all racial and ethnic groups, sort results by product type (including whether they contain dyes/coloring, bleach, highlights, or perms), and decide if the FDA should require extra safety testing for these products.

Key points

• Who is affected: People who use chemical hair straighteners, especially women of color, but also other groups at risk for uterine cancer.
• What changes: A national study will review past research, analyze product types, and recommend whether added FDA testing rules are needed for hair straightening products.
• When: The study plan is due within 45 days, the study must start within 180 days, and a final report is due within 2 years of the law taking effect.